Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy

References

• Morvan MG, Lanier LL. NK cells and cancer: you can teach innate cells new tricks. Nat Rev Cancer. 2016 Jan;16(1):7–19. PubMed PMID: 26694935; eng.
   PubMed Web of Science ®Google Scholar
• Carotta S. Targeting NK cells for anticancer immunotherapy: clinical and preclinical approaches. Front Immunol. 2016;7:152. PubMed PMID: 27148271; PubMed Central PMCID: PMC4838611. eng.
   PubMed Web of Science ®Google Scholar
• Carrega P, Ferlazzo G. Natural killers are made not born: how to exploit NK cells in lung malignancies. Front Immunol. 2017;8:277. PubMed PMID: 28348567; PubMed Central PMCID: PMC5346886. eng.
   PubMed Web of Science ®Google Scholar
• Guillerey C, Huntington ND, Smyth MJ. Targeting natural killer cells in cancer immunotherapy. Nat Immunol. 2016 Aug 19;17(9):1025–1036. PubMed PMID: 27540992; eng.
   PubMed Web of Science ®Google Scholar
• Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011 Nov 11;147(4):728–741. PubMed PMID: 22078875; eng.
   PubMed Web of Science ®Google Scholar
• Sui X, Chen R, Wang Z, et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013 Oct 10;4:e838. PubMed PMID: 24113172; PubMed Central PMCID: PMC3824660. eng.
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Pietrocola F, Bravo-San Pedro JM, et al. Autophagy in malignant transformation and cancer progression. EMBO J. 2015 Apr 01;34(7):856–880. PubMed PMID: 25712477; PubMed Central PMCID: PMC4388596. eng.
   PubMed Web of Science ®Google Scholar
• Ozpolat B, Benbrook DM. Targeting autophagy in cancer management - strategies and developments. Cancer Manag Res. 2015;7:291–299. PubMed PMID: 26392787; PubMed Central PMCID: PMC4573074. eng.
   PubMed Web of Science ®Google Scholar
• Noman MZ, Buart S, Van Pelt J, et al. The cooperative induction of hypoxia-inducible factor-1 alpha and STAT3 during hypoxia induced an impairment of tumor susceptibility to CTL-mediated cell lysis. J Immunol. 2009 Mar 15;182(6):3510–3521. PubMed PMID: 19265129; eng.
   PubMed Web of Science ®Google Scholar
• Noman MZ, Janji B, Kaminska B, et al. Blocking hypoxia-induced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res. 2011 Sep 15;71(18):5976–5986. PubMed PMID: 21810913; eng.
   PubMed Web of Science ®Google Scholar
• Akalay I, Janji B, Hasmim M, et al. Epithelial-to-mesenchymal transition and autophagy induction in breast carcinoma promote escape from T-cell-mediated lysis. Cancer Res. 2013 Apr 15;73(8):2418–2427. PubMed PMID: 23436798; eng.
   PubMed Web of Science ®Google Scholar
• Akalay I, Janji B, Hasmim M, et al. EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction. Autophagy. 2013 Jul;9(7):1104–1106. PubMed PMID: 23635487; PubMed Central PMCID: PMC3722321. eng.
   PubMed Web of Science ®Google Scholar
• Baginska J, Viry E, Berchem G, et al. Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia. Proc Natl Acad Sci USA. 2013 Oct 22;110(43):17450–17455. PubMed PMID: 24101526; PubMed Central PMCID: PMC3808626. eng.
   PubMed Web of Science ®Google Scholar
• Tittarelli A, Janji B, Van Moer K, et al. The selective degradation of synaptic connexin 43 protein by hypoxia-induced autophagy impairs natural killer cell-mediated tumor cell killing. J Biol Chem. 2015 Sep 25;290(39):23670–23679. PubMed PMID: 26221040; PubMed Central PMCID: PMC4583044. eng.
   PubMed Web of Science ®Google Scholar
• Janji B, Viry E, Moussay E, et al. The multifaceted role of autophagy in tumor evasion from immune surveillance. Oncotarget. 2016 Apr 05;7(14):17591–17607. PubMed PMID: 26910842; PubMed Central PMCID: PMC4951235. eng.
   PubMedGoogle Scholar
• Li-Weber M. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines). Int J Cancer. 2015 Oct 15;137(8):1791–1799. PubMed PMID: 24895251; eng.
   PubMed Web of Science ®Google Scholar
• Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 2004 Nov;294(1–2):15–22. PubMed PMID: 15604012; eng.
   PubMed Web of Science ®Google Scholar
• Messai Y, Noman MZ, Hasmim M, et al. ITPR1 protects renal cancer cells against natural killer cells by inducing autophagy. Cancer Res. 2014 Dec 01;74(23):6820–6832. PubMed PMID: 25297632; eng.
   PubMed Web of Science ®Google Scholar
• Iwasaki S, Floor SN, Ingolia NT. Rocaglates convert DEAD-box protein eIF4A into a sequence-selective translational repressor. Nature. 2016 Jun 23;534(7608):558–561. PubMed PMID: 27309803; PubMed Central PMCID: PMC4946961. eng.
   PubMed Web of Science ®Google Scholar
• Buchser WJ, Laskow TC, Pavlik PJ, et al. Cell-mediated autophagy promotes cancer cell survival. Cancer Res. 2012 Jun 15;72(12):2970–2979. PubMed PMID: 22505650; PubMed Central PMCID: PMC3505669. eng.
   PubMed Web of Science ®Google Scholar
• Viry E, Baginska J, Berchem G, et al. Autophagic degradation of GZMB/granzyme B: a new mechanism of hypoxic tumor cell escape from natural killer cell-mediated lysis. Autophagy. 2014 Jan;10(1):173–175. PubMed PMID: 24248158; PubMed Central PMCID: PMC4389872. eng.
   PubMed Web of Science ®Google Scholar
• Viry E, Noman MZ, Arakelian T, et al. Hijacker of the antitumor immune response: autophagy is showing its worst facet. Front Oncol. 2016;6:246. PubMed PMID: 27917371; PubMed Central PMCID: PMC5114287. eng.
   PubMed Web of Science ®Google Scholar
• Yurugi H, Marini F, Weber C, et al. Targeting prohibitins with chemical ligands inhibits KRAS-mediated lung tumours. Oncogene. 2017 Apr 17;36:5914. PubMed PMID: 28414306; eng.
   Web of Science ®Google Scholar
• Becker MS, Muller PM, Bajorat J, et al. The anticancer phytochemical rocaglamide inhibits Rho GTPase activity and cancer cell migration. Oncotarget. 2016 Aug 09;7(32):51908–51921. PubMed PMID: 27340868; PubMed Central PMCID: PMC5239523. eng.
   PubMedGoogle Scholar
• Wu Y, Giaisi M, Kohler R, et al. Rocaglamide breaks TRAIL-resistance in human multiple myeloma and acute T-cell leukemia in vivo in a mouse xenogtraft model. Cancer Lett. 2017 Mar 28;389:70–77. PubMed PMID: 27998762; eng.
   PubMed Web of Science ®Google Scholar
• Bleumink M, Kohler R, Giaisi M, et al. Rocaglamide breaks TRAIL resistance in HTLV-1-associated adult T-cell leukemia/lymphoma by translational suppression of c-FLIP expression. Cell Death Differ. 2011 Feb;18(2):362–370. PubMed PMID: 20706274; PubMed Central PMCID: PMC3131883. eng.
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Abdelmohsen K, Abe A, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016;12(1):1–222. PubMed PMID: 26799652; PubMed Central PMCID: PMC4835977. eng.
   PubMed Web of Science ®Google Scholar
• Hurley JH, Young LN. Mechanisms of autophagy initiation. Annu Rev Biochem. 2017 Jun 20;86:225–244. PubMed PMID: 28301741; eng.
   PubMed Web of Science ®Google Scholar
• Park JM, Jung CH, Seo M, et al. The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy. 2016;12(3):547–564. PubMed PMID: 27046250; PubMed Central PMCID: PMC4835982. eng.
   PubMed Web of Science ®Google Scholar
• Jung CH, Ro SH, Cao J, et al. mTOR regulation of autophagy. FEBS Lett. 2010 Apr 02;584(7):1287–1295. PubMed PMID: 20083114; PubMed Central PMCID: PMC2846630. eng.
   PubMed Web of Science ®Google Scholar
• Kim J, Kundu M, Viollet B, et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 2011 Feb;13(2):132–141. PubMed PMID: 21258367; PubMed Central PMCID: PMC3987946. eng.
   PubMed Web of Science ®Google Scholar
• Mamane Y, Petroulakis E, LeBacquer O, et al. mTOR, translation initiation and cancer. Oncogene. 2006 Oct 16;25(48):6416–6422. PubMed PMID: 17041626; eng.
   PubMed Web of Science ®Google Scholar
• Dunlop EA, Hunt DK, Acosta-Jaquez HA, et al. ULK1 inhibits mTORC1 signaling, promotes multisite Raptor phosphorylation and hinders substrate binding. Autophagy. 2011 Jul;7(7):737–747. 15491 [pii]. PubMed PMID: 21460630; PubMed Central PMCID: PMC3149699. eng.
   PubMed Web of Science ®Google Scholar
• Messai Y, Noman MZ, Janji B, et al. The autophagy sensor ITPR1 protects renal carcinoma cells from NK-mediated killing. Autophagy. 2015 Feb 25. PubMed PMID: 25714778; eng. DOI:10.1080/15548627.2015.1017194
   PubMedGoogle Scholar
• Parys JB, Decuypere JP, Bultynck G. Role of the inositol 1,4,5-trisphosphate receptor/Ca2+-release channel in autophagy. Cell Commun Signal. 2012 Jul 06;10(1):17. PubMed PMID: 22770472; PubMed Central PMCID: PMC3413604. eng.
   PubMed Web of Science ®Google Scholar
• Sadlish H, Galicia-Vazquez G, Paris CG, et al. Evidence for a functionally relevant rocaglamide binding site on the eIF4A-RNA complex. ACS Chem Biol. 2013 Jul 19;8(7):1519–1527. PubMed PMID: 23614532; PubMed Central PMCID: PMC3796129. eng.
   PubMed Web of Science ®Google Scholar
• Wang X, Lee DA, Wang Y, et al. Membrane-bound interleukin-21 and CD137 ligand induce functional human natural killer cells from peripheral blood mononuclear cells through STAT-3 activation. Clin Exp Immunol. 2013 Apr;172(1):104–112. PubMed PMID: 23480190; PubMed Central PMCID: PMC3719936. eng.
   PubMed Web of Science ®Google Scholar
• Gong C, Yao C, Xu Z, et al. Enhancement of NK cell-mediated lysis of non-small lung cancer cells by nPKC activator, ingenol 3,20 dibenzoate. Mol Immunol. 2017 Mar;83:23–32. PubMed PMID: 28092804; eng.
   PubMed Web of Science ®Google Scholar
• Brown CE, Wright CL, Naranjo A, et al. Biophotonic cytotoxicity assay for high-throughput screening of cytolytic killing. J Immunol Methods. 2005 Feb;297(1–2):39–52. PubMed PMID: 15777929; eng.
   PubMed Web of Science ®Google Scholar